SJS Investment Consulting’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.67K Buy
73
+10
+16% +$657 ﹤0.01% 1416
2026
Q1
$4.49K Sell
63
-155
-71% -$12.2K ﹤0.01% 1066
2025
Q4
$17.9K Buy
218
+2
+0.9% +$156 ﹤0.01% 661
2025
Q3
$16.2K Hold
216
﹤0.01% 560
2025
Q2
$16K Sell
216
-6
-3% -$418 ﹤0.01% 304
2025
Q1
$17.9K Buy
222
+24
+12% +$2.06K ﹤0.01% 296
2024
Q4
$15.5K Sell
198
-50
-20% -$4.25K ﹤0.01% 307
2024
Q3
$23.3K Buy
248
+22
+10% +$1.85K ﹤0.01% 266
2024
Q2
$17.6K Buy
226
+3
+1% +$245 ﹤0.01% 279
2024
Q1
$20.3K Buy
223
+177
+385% +$14.7K ﹤0.01% 279
2023
Q4
$3.56K Buy
46
+1
+2% +$70 ﹤0.01% 469
2023
Q3
$3.06K Buy
45
+12
+36% +$873 ﹤0.01% 476
2023
Q2
$2.68K Buy
33
+17
+106% +$1.36K ﹤0.01% 492
2023
Q1
$1.31K Buy
+16
New +$1.14K ﹤0.01% 766

Other funds holding GEHC

SJS Investment Consulting's GEHC Position: Q2 2026 in Review

SJS Investment Consulting increased its GE HealthCare (GEHC) stake by 16% in Q2 2026, buying an estimated $657 and bringing the position to 73 shares worth $4.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

SJS Investment Consulting first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $23.3K in Q3 2024. 702 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • SJS Investment Consulting held 73 shares of GE HealthCare worth $4.67K as of Q2 2026.
  • SJS Investment Consulting bought 10 GE HealthCare shares in Q2 2026, an estimated $657.
  • GE HealthCare made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1416 holding.
  • SJS Investment Consulting first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • SJS Investment Consulting's GE HealthCare position peaked at $23.3K in Q3 2024.
  • 702 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.